Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma
2017 · New England Journal of Medicine · 738 citations
https://doi.org/10.1056/nejmoa1708984
A
Andrea Gallamini
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
393
Papers
16.0K
Citations
64
h-index
140
i10-index
Andrea Gallamini is an academic researcher from Centre Antoine Lacassagne. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Lung Cancer Treatments and Mutations & Medical Imaging Techniques and Applications. The author has an h-index of 64, co-authored 335 publications.
ORCID: 0000-0002-2054-7412Papers by this author
worksReport on the First International Workshop on interim-PET scan in lymphoma
2009 · Leukemia & lymphoma/Leukemia and lymphoma · 731 citations
https://doi.org/10.1080/10428190903040048
Report on the First International Workshop on interim-PET scan in lymphoma
2009 · Leukemia & lymphoma/Leukemia and lymphoma · 731 citations
https://doi.org/10.1080/10428190903040048
Positron Emission Tomography (PET) in Oncology
2014 · Cancers · 308 citations
https://doi.org/10.3390/cancers6041821
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B
2004 · British Journal of Cancer · 183 citations
https://doi.org/10.1038/sj.bjc.6601460
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat